Caliper Rings NASDAQ Opening Bell, Interview with Kevin Hrusovsky, CEO
"Click Here to view press release & video"Come join us at one of our global 2012 PerkinElmer Owners Group venues!
Click Here!
Latest News
Nov 7, 2011
PerkinElmer Completes Acquisition of Caliper Life SciencesNov 7, 2011
Caliper CEO Kevin Hrusovsky Presented Vision for Revolutionizing MedicineNov 3, 2011
Caliper Life Sciences Reports Third Quarter 2011 ResultsNov 2, 2011
Caliper Launches New Platform for Drug Safety Prediction and Oncology ResearchOct 24, 2011
DxTerity and Caliper Life Sciences Partner to Deliver NEAT® Multiplex ... More NewsEvents
2012 Owners Group MeetingsMay 31, 2012
Webinar - 3D Fluorescence ImagingJune 6-8, 2012
East Coast - PerkinElmer Owners Group MeetingJune 12-13, 2012
Europe - PerkinElmer Owners GroupJune 13-16, 2012
International Society for Stem Cell Research (ISSR)June 16-19, 2012
American Society for Microbiology (ASM) More EventsIn Vitro & In Vivo Outsourcing
Caliper provides a wide-range of in vitro & in vivo contract research services through our Discovery Alliances & Services (CDAS) business unit. We offer outsourcing solutions in many areas including Molecular Screening & Profiling, Functional Pharmacology, Drug Safety Assessment, ADME-Tox, PK/PD and In vivo Drug Efficacy Studies.
Learn More About our Screening Assays & Programs through CDAS
Support
We put our Customers First allowing them to focus on their number one priority.Better science...today.
Learn More About Our Support
This month's highlight - Please join us at our East Coast PerkinElmer Owners Group meeting on June 7-8! Learn More